LEADER 01461oam  2200433I  450 
001 9910704912403321
005 20140106154709.0
035   $a(CKB)5470000002446625
035   $a(OCoLC)866908154
035   $a(OCoLC)995470000002446625
035   $a(EXLCZ)995470000002446625
100   $a20131230d2005      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aAnabolic-androgenic steroids $eincidence of use and health implications /$fguest authors, Charles E. Yesalis, Michael S. Bahrke
210  1$aWashington, D.C. :$cPresident's Council on Physical Fitness and Sports,$d2005.
215   $a1 online resource (8 pages)
225 1 $aResearch digest. Series 5 ;$vno. 5
300   $aTitle from title screen (viewed Dec. 18, 2013).
300   $a"March 2005."
320   $aIncludes bibliographical references (page 8).
517   $aAnabolic-androgenic steroids 
606   $aAnabolic steroids
606   $aAthletes$xDrug use$zUnited States
615  0$aAnabolic steroids.
615  0$aAthletes$xDrug use
700   $aYesalis$b Charles$01403496
702   $aBahrke$b Michael S.$f1949-
712 02$aPresident's Council on Physical Fitness and Sports (U.S.),
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910704912403321
996   $aAnabolic-androgenic steroids$93476332
997   $aUNINA